PERSPECTA

News from every angle

Back to headlines

Telix Pharmaceuticals Reports Q1 Results and Reaffirms FY26 Outlook

Telix Pharmaceuticals announced its first-quarter financial results, confirming its previously stated outlook for fiscal year 2026.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.